316 related articles for article (PubMed ID: 16904828)
1. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
3. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease.
Tröster AI; Fields JA; Paolo AM; Koller WC
J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
Feldman B; Chapman J; Korczyn AD
Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.
López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME
Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455
[TBL] [Abstract][Full Text] [Related]
6. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
7. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
8. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.
Zareparsi S; Kaye J; Camicioli R; Grimslid H; Oken B; Litt M; Nutt J; Bird T; Schellenberg G; Payami H
Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478
[TBL] [Abstract][Full Text] [Related]
11. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.
Geschwind D; Karrim J; Nelson SF; Miller B
Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
13. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
14. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
[TBL] [Abstract][Full Text] [Related]
15. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
17. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
Saarela MS; Lehtimäki T; Rinne JO; Hervonen A; Jylhä M; Röyttä M; Ahonen JP; Mattila KM
Neurosci Lett; 2004 Sep; 367(3):336-9. PubMed ID: 15337261
[TBL] [Abstract][Full Text] [Related]
18. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans].
Hao Y; Xie H; Xu L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703
[TBL] [Abstract][Full Text] [Related]
19. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
